Features Partner Sites Information LinkXpress
Sign In
Demo Company

New Benchtop Robot Introduced for Flexible Automated Workflows

By BiotechDaily International staff writers
Posted on 29 Jan 2013
Print article
Image: The Thermo Scientific VALet benchtop robot (Photo courtesy of Thermo Fisher).
Image: The Thermo Scientific VALet benchtop robot (Photo courtesy of Thermo Fisher).
A new, adaptable benchtop robot increases productivity by providing flexible, high-capacity microplate storage and movement for a broad range of laboratory applications.

Thermo Fisher Scientific (Waltham, MA, USA) has now launched the Thermo Scientific VALet, a benchtop robot enabling simple, configurable laboratory automation. Adaptable to various user needs, VALet has been designed to allow multiple hotel positioning for customizable, high density microplate movement and storage, which can increase productivity in a limited work space. With four-axis plus servo-gripper, and the capacity to access both single and multiple arrayed nests, VALet is designed to be a robot highly suitable for instrument loading functions.

Built for the dynamic laboratory environment, the Thermo Scientific VALet caters to a broad range of applications, from simple instrument loading to more complex, integrated workflows. With its flexible design and on-board re-grip station, the high capacity microplate storage can be placed on the left, right, or at the front to optimize its fit in the laboratory. User-defined choices also include random or sequential storage access, giving a capacity of up to 45 or 120 microplates, respectively. VALet has been designed to enable the quick addition of connecting carousels, which can be mixed and matched to provide enhanced storage and workflow capacity tailored to specific requirements. This ability to accept multiple storage expansion options makes VALet an adaptable robot in the microplate mover sector, with considerable upgrade capability.

Integration of “Thermotor” technology allows the VALet to be controlled directly from a computer without the need for additional controllers. This feature is designed to save valuable laboratory space, to permit a quieter working environment, and to negate the need for dedicated automation engineers. In combination with the Thermo Scientific “Momentum” scheduling software, including the newly launched Momentum 3.2, the VALet bench-top robot provides users with a platform for creating, operating, and fulfilling automated workflow needs, accurately and efficiently.

Related Links:

Thermo Fisher Scientific, Inc.
Thermo Scientific VALet

Print article



view channel
Image: Glioblastoma multiforme (GBM) (Photo courtesy of the University of California, San Diego School of Medicine).

How Blocking TROY Signaling Slows Brain Cancer Growth

Cancer researchers have found how the low molecular weight drug propentofylline (PPF) slows the growth of the aggressive brain tumor glioblastoma multiforme (GBM). This form of brain cancer is the most... Read more


view channel
Image: A partially completed three-dimensional printed airway from nostril to trachea with fine structure of the nasal cavity showing (Photo courtesy of Dr. Rui Ni, Pennsylvania State University).

The Structure of the Nasal Cavity Channels Food Smells into the Nose and Avoids the Lungs

Three-dimensional printing technology was used to create a model of the nasal cavity that enabled researchers to demonstrate why the smell of food goes into the nose rather than down into the lungs.... Read more


view channel

Molecular Light Shed on “Dark” Cellular Receptors

Scientists have created a new research tool to help find homes for orphan cell-surface receptors, toward better understanding of cell signaling, developing new therapeutics, and determining causes of drug side-effects. The approach may be broadly useful for discovering interactions of orphan receptors with endogenous, naturally... Read more


view channel

Purchase of Biopharmaceutical Company Will Boost Development of Nitroxyl-Based Cardiovascular Disease Drugs

A major international biopharmaceutical company has announced the acquisition of a private biotech company that specializes in the development of drugs for treatment of cardiovascular disease. Bristol-Myers Squibb Co. (New York, NY, USA) has initiated the process to buy Cardioxyl Pharmaceuticals Inc. (Chapel Hill, NC, USA).... Read more
Copyright © 2000-2015 Globetech Media. All rights reserved.